Searched for
PRICE TO RETAILER CANCER MEDICINES
'Inflated medicine prices are daylight robbery': SC pulls up pharma companies over huge MRP-PTR gapSupreme Court on Tuesday questioned the wide gap between the price to retailer and MRP of some cancer medicines, calling inflated pricing a...- European pharma chiefs warn region risks losing ground to America, ChinaDrugmakers for months have been warning they could curtail investments and delay the release of new medications in Europe, widening a dispa...
- Drug regulator warns against prolonged use of painkillers, antibioticsIndia’s drug regulator has warned against the indiscriminate, repeated or prolonged use of painkillers and antibiotics, citing risks includ...
- 'Retailers likely to pass UPI MDR to consumers'Retail associations are voicing concerns that the proposed UPI charge will inevitably be transferred to consumers, either as new fees on bi...
- Global Market: European shares rise as oil slide boosts risk appetiteEuropean shares rose as technology stocks led gains and falling oil prices eased inflation concerns. The STOXX 600 advanced 0.56%, while in...
- Biocon arm gets positive EMA panel recommendation for breast cancerbiosimilar PebrilzoBiocon Biologics has received a positive recommendation from the European Medicines Agency’s CHMP for its Pertuzumab biosimilar, Pebrilzo, ...
- ‘I couldn’t understand it’: Dr Pal reveals why a cancer patient’s laughter left him thinking long after the consultationGastro doctor Dr Pal recalled a cancer patient who had been given approximately two years to live and had lost his wife. The man’s biggest ...
- SS Retail IPO allotment likely today: GMP signals 35% listing gain; here's how to check statusSS Retail IPO allotment status is likely to be finalised today following a strong 103.30x subscription. Driven by robust retail and institu...
- Fake drugs: Karnataka cancels 16 licenses, suspends 8 including that of Pfizer depotKarnataka's FDA raided a farmhouse, seizing spurious drugs and machinery valued at Rs 5.05 crore. The operation allegedly repackaged and re...
- Colorectal cancer is rising in adults under 50 and is now their leading cancer killer; warning signs and risk factors younger people should knowColorectal cancer has now emerged as the top cause of cancer mortality among Americans below fifty years old. This trend starkly contrasts ...
- Cancer Weekly Horoscope (September 19–25, 2026): Personal Transformation Brings Confidence, Clarity and New OpportunitiesCancer Weekly Horoscope for September 19–25, 2026, highlights personal growth, stronger confidence and important decisions. Jupiter encoura...
- No meat or fish for over 40 years. Vegetarian 90-year-old bodybuilder from Japan reveals diet that keeps him fit. One of his favourite foods can add 13 years to your lifespanHe is fit as a fiddle at 90 and is a fitness goal. Toshisuke Kanazawa, a renowned bodybuilder from Japan, recently went viral after he bagg...
- Cancer Horoscope This Week (Sep 21-27): Stay Calm Early On as Career and Relationship Opportunities DevelopYour Cancer Weekly Horoscope brings a week of emotional awareness, personal responsibility, and gradual progress. You may feel more sensiti...
- Kim Kardashian has esophagitis: What is it, when to see the doctor, and how is it different from esophageal cancer that killed her father?Kim Kardashian revealed her esophagitis diagnosis during a reality show trailer. This condition involves inflammation of the esophagus, whi...
- Agonisingly slow clinical trial is stopping Indian pharma become global innovator from supplierIndia's regulatory hurdles slow down early-stage drug trials significantly. This complexity causes Indian companies to conduct crucial firs...
- Fake Cancer Drug Racket Busted: A man was selling counterfeit medicines to 100 hospitals across Bengaluru and other statesA major fake cancer drug racket has been busted in Karnataka, with investigators alleging that a licensed pharmacist supplied counterfeit m...
- Short-term headwind? Yes. But the structure stays intact: 5 large-cap stocks with upside potential of up to 19%Wise men on the street will tell you it is foolish to try and time the market. And attempting to do so in the midst of a raging war is prob...
- AstraZeneca's breast cancer drug fails in late-stage trialAstraZeneca's breast cancer drug Etcamah did not meet its main goal in a late-stage trial. The drug showed only a numerical improvement whe...
- Biocon shares rise 3% after Rs 638-crore block deal; Active Pine likely sellerBiocon shares rose after a block deal involving around 1.65 crore shares. Investor Active Pine was reportedly looking to sell up to 1.66 cr...
- Biocon shares rise 2% on 10-year Pertuzumab supply deal for breast cancer therapy in BrazilBiocon shares rose after the company secured a 10-year Pertuzumab supply contract in Brazil. The consortium with Bahiafarma and Bionovis re...
Load More
